# 2026-08813: Corneal Storage Fluid with Fungus Fighters Reclassified

2026-08813, Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals, is a Federal Register rule from Health and Human Services Department, Food and Drug Administration published 2026-05-06, effective 2026-05-06; PRIA reads it as touching household money (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2026-08813
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-08813
- Title: Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals
- Type: Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 24346
- Published: 2026-05-06
- Effective: 2026-05-06
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

Corneal Storage Fluid with Fungus Fighters Reclassified

## Summary

The FDA is officially putting corneal storage fluids with preservatives and antifungals into a safer, easier-to-manage category called Class II. This change helps make sure these eye care products are safe and effective while speeding up access to new, helpful devices. Starting May 6, 2026, companies will follow these new rules, which could save time and money by cutting down on red tape.

## Abstract

The Food and Drug Administration (FDA) is classifying the corneal storage medium with preservatives including antifungals into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the corneal storage medium with preservatives including antifungals. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

## Effects PRIA read

- Class II listing may speed patient access: benefit, medium. The FDA officially classified corneal storage medium with preservatives including antifungals as Class II (special controls). This change is effective May 6, 2026 (and was applicable May 2, 2022) and the agency says the change will enhance patients' access to beneficial innovative devices by reduci…
- Manufacturers must meet special controls and 510(k): mixed, medium. Corneal storage media with preservatives including antifungals are Class II devices and therefore subject to premarket notification under section 510(k). Manufacturers must comply with the listed special controls (for example: non-clinical performance testing, sterility demonstration, biocompatibil…
- Creates a predicate for future devices: benefit, medium. FDA states that when it classifies a device into Class II via the De Novo process, the device can serve as a predicate for future devices of that type, allowing other sponsors to use the less-burdensome 510(k) process rather than De Novo or premarket approval. This makes it easier for subsequent co…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-08813 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/06/2026-08813/medical-devices-ophthalmic-devices-classification-of-the-corneal-storage-medium-with-preservatives)
- [2026-08813 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-06/pdf/2026-08813.pdf)

## Related
- [Previous: 2026-08812, Medical Devices; Immunology and Microbiology Devices; Classification of the Cir…](https://policyrisk.com/federal-register/2026-08812)
- [Next: 2026-08822, Safety Zone; Key West Paddle Classic, Key West, FL](https://policyrisk.com/federal-register/2026-08822)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-08813 (as of 2026-06-11).
